Outcomes of liver transplantation in non-alcoholic steatohepatitis (NASH) versus non-NASH associated hepatocellular carcinoma
HPB · 2023
DOI: 10.1016/j.hpb.2023.01.019 ↗Kurz gefasst
Fachartikel in der Zeitschrift HPB, 2023. Verfasst von Luckshi Rajendran und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Division of General Surgery, University of Toronto, Toronto, Canada. Electronic address: https://twitter.com/luckseee. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Transplantation, Liver Neoplasms, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Non-alcoholic steatohepatitis (NASH)-associated hepatocellular carcinoma (HCC) is a rising indication for liver transplantation. This unique population, with multiple comorbidities, has potential for worse post-transplant outcomes. We compared post-transplant survival of NASH and non-NASH HCC patients using a large cohort. METHODS: Adults transplanted for HCC between 2008 and 2018, from United Network for Organ Sharing (UNOS) and University Health Network (UHN) databases were divided into two populations: NASH and non-NASH. Recipient characteristics and post-transplant survival were compared. Subgroup analyses were performed within and beyond Milan criteria. RESULTS: 2071 of 20,672 (10.0%) patients underwent transplantation for NASH HCC, with annual proportional increase of 1.2%UHN (p = 0.02) and 1.3%UNOS (p < 0.001). The 1-,3-,5-year post-transplant survival were 90.8%, 83.9%, 76.3% NASH HCC versus 91.9%, 82.1%, 74.9% non-NASH HCC (p = 0.94). No survival differences were observed in populations within or beyond Milan. Competing-risk analysis demonstrated no differences in risk for cardiovascular-related death (HR1.24, 95%CI 0.87-1.55, p = 0.16), or HCC recurrence-related death (HR1.21, 95%CI 0.89-1.65, p = 0.23). NASH HCC patients had lower risk of liver-related deaths (HR0.57, 95%CI 0.34-0.98, p = 0.04). DISCUSSION: NASH HCC is a rising indication for liver transplantation. Despite demographic differences, no post-transplantation survival differences were observed between NASH and non-NASH HCC. This justifies equivalent organ allocation, irrespective of NASH status.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Surgery, Division of General Surgery, University of Toronto, Toronto, Canada. Electronic address: https://twitter.com/luckseee.
- Multi-Organ Transplant Program, University Health Network, Toronto, Canada; Toronto Centre for Liver Disease, University Health Network, Toronto, Canada; Institute of Health Policy, Management & Evaluation, University o…
- Multi-Organ Transplant Program, University Health Network, Toronto, Canada; Department of Surgery, Henry Ford Hospital, Detroit, MI, USA; Department of Surgical Sciences, Akademiska Sjukhuset, Uppsala University, Uppsal…
- Multi-Organ Transplant Program, University Health Network, Toronto, Canada; Department of Surgery, Division of HPB & Transplant Surgery, Erasmus MC Transplant Institute, University Medical Centre Rotterdam, Rotterdam, t…
- Department of Health Services Research and Policy, London School of Hygiene and Tropical Medicine, London, United Kingdom; Institute of Liver Studies, Kings College Hospital, Denmark Hill, London, United Kingdom.
- Multi-Organ Transplant Program, University Health Network, Toronto, Canada; Department of Surgery, Westmead Hospital, Sydney, Australia.
Zitieren
APA
Rajendran, L., Murillo Perez, C. F., Ivanics, T., Claasen, M. P. A. W., Hansen, B. E., Wallace, D., Yoon, P. D., & Sapisochin, G. (2023). Outcomes of liver transplantation in non-alcoholic steatohepatitis (NASH) versus non-NASH associated hepatocellular carcinoma. HPB. https://doi.org/10.1016/j.hpb.2023.01.019
Vancouver
Rajendran L, Murillo Perez CF, Ivanics T, Claasen MPAW, Hansen BE, Wallace D, et al. Outcomes of liver transplantation in non-alcoholic steatohepatitis (NASH) versus non-NASH associated hepatocellular carcinoma. HPB. 2023. doi:10.1016/j.hpb.2023.01.019
BibTeX
@article{Rajendran2023,
author = {Rajendran, Luckshi and Murillo Perez, Carla F and Ivanics, Tommy and Claasen, Marco P A W and Hansen, Bettina E and Wallace, David and Yoon, Peter D and Sapisochin, Gonzalo},
title = {Outcomes of liver transplantation in non-alcoholic steatohepatitis (NASH) versus non-NASH associated hepatocellular carcinoma},
journal = {HPB},
year = {2023},
doi = {10.1016/j.hpb.2023.01.019}
}
EUVIMED